ProfileGDS5822 / ILMN_2619773
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 66% 46% 47% 65% 42% 68% 39% 50% 36% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 136.766
GSM1276600PDAC Late Ablation Control 222.246
GSM1276601PDAC Late Ablation Control 318.447
GSM1276602PDAC Late Ablation 132.865
GSM1276603PDAC Late Ablation 219.242
GSM1276604PDAC Late Ablation 350.468
GSM1303940PDAC Late Ablation_anti-CTLA4 118.339
GSM1303941PDAC Late Ablation_anti-CTLA4 225.250
GSM1303942PDAC Late Ablation_anti-CTLA4 317.236